Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial

Abstract
No abstract available
Funding Information
  • Department of Health and Social Care (project number 16/107/01)
  • Korean Ministry of Health and Welfare (HI15C2971)

This publication has 31 references indexed in Scilit: